Gaia Pellegatta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gaia Pellegatta has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Edoardo Savarino
Department of Surgery, Oncology and Gastroenterology University of Padova Padova Italy
12 shared publications Vincenzo Savarino
B Gastrointestinal Unit, Department of Internal Medicine and Medical Specialties , University of Genoa , Genoa , Italy
7 shared publications- Alessandro Fugazza
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy
6 shared publications - Alessandro Repici
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy
6 shared publications - Giorgia Bodini
Department of Internal Medicine and Medical Specialities, Division of Gastroenterology, IRCCS “San Martino” Hospital, University of Genoa, Genoa, Italy
6 shared publications - Andrea Anderloni
Università di Pavia, Italy
5 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (7) , e70271
Evolution of Endoscopic and Histologic Assessment of Eosinophilic Esophagitis in Europe and Evolution of the Diagnostic Delay: Data From the EUREOS EoE CONNECT Registry
Background: Endoscopy with histopathological assessment of esophageal biopsies is the cornerstone for the diagnosis and phenotypic characterization of eosinophilic esophagitis (EoE). Objective: To evaluate temporal trends in endoscopic assessment and biopsy sampling practices for EoE in a large European cohort and their association with temporal trends in diagnostic delay (DD). Methods: A cross‐sectional analysis was conducted using multicenter data from the EoE CONNECT registry. Endoscopic findings and biopsy data at diagnosis were analyzed. Temporal trends in biopsy strategies, EREFS implementation, and DD were assessed. Diagnostic sensitivity of individual esophageal segments and their combinations was evaluated in patients undergoing multi‐segment sampling. Associations between guideline publication and biopsy practices were analyzed using logistic regression models. Results: A total of 3298 patients were included. Biopsies were obtained from one esophageal segment in 12.6% of patients, two segments in 63.6%, and three segments in 23.8%. Adherence to guideline‐recommended biopsy strategies improved over time, with reduced single‐segment sampling and increased use of ≥ 2 segments. Distal esophageal biopsies provided the highest diagnostic sensitivity, and sampling that included the distal segment achieved sensitivity above 97%, particularly when combined with middle esophageal biopsies. EREFS reporting increased from 88–90% to over 98% in recent years. DD decreased significantly over time (approximately 0.7 years per calendar year), accompanied by a shift from mixed/stricturing to inflammatory phenotypes. Conclusion: Increased alignment with international guidelines, reflected by standardized endoscopic reporting and multi‐segment biopsy protocols, was associated with improved diagnostic sensitivity, reduced DD, and fewer fibrostricturing presentations.
- 12 August 2026
- Published by Wiley in United European Gastroenterology Journal
- Vol. 14 (7) , e70271
Open AccessEvolution of Endoscopic and Histologic Assessment of Eosinophilic Esophagitis in Europe and Evolution of the Diagnostic Delay: Data From the EUREOS EoE CONNECT Registry
Background: Endoscopy with histopathological assessment of esophageal biopsies is the cornerstone for the diagnosis and phenotypic characterization of eosinophilic esophagitis (EoE). Objective: To evaluate temporal trends in endoscopic assessment and biopsy sampling practices for EoE in a large European cohort and their association with temporal trends in diagnostic delay (DD). Methods: A cross‐sectional analysis was conducted using multicenter data from the EoE CONNECT registry. Endoscopic findings and biopsy data at diagnosis were analyzed. Temporal trends in biopsy strategies, EREFS implementation, and DD were assessed. Diagnostic sensitivity of individual esophageal segments and their combinations was evaluated in patients undergoing multi‐segment sampling. Associations between guideline publication and biopsy practices were analyzed using logistic regression models. Results: A total of 3298 patients were included. Biopsies were obtained from one esophageal segment in 12.6% of patients, two segments in 63.6%, and three segments in 23.8%. Adherence to guideline‐recommended biopsy strategies improved over time, with reduced single‐segment sampling and increased use of ≥ 2 segments. Distal esophageal biopsies provided the highest diagnostic sensitivity, and sampling that included the distal segment achieved sensitivity above 97%, particularly when combined with middle esophageal biopsies. EREFS reporting increased from 88–90% to over 98% in recent years. DD decreased significantly over time (approximately 0.7 years per calendar year), accompanied by a shift from mixed/stricturing to inflammatory phenotypes. Conclusion: Increased alignment with international guidelines, reflected by standardized endoscopic reporting and multi‐segment biopsy protocols, was associated with improved diagnostic sensitivity, reduced DD, and fewer fibrostricturing presentations.
- Open Access
- 8 November 2024
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (10) , 1388-1398
Sex‐related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registry
Background: Eosinophilic esophagitis (EoE) predominantly affects males across all ages; however, little is known about sex differences for other aspects of EoE. Objective: To investigate associations between sex and clinical presentation, endoscopic features, treatment choice and response in EoE patients in real‐world practice. Methods: Cross‐sectional analysis of the multicenter EoE CONNECT registry. The independent contribution of patients' sex and other relevant variables were statistically assessed by multivariate models. Results: A total of 2976 patients (76% male) were evaluated. Males were diagnosed at a younger age compared to females (32.7 ± 14.8 vs. 34.8 ± 15.6 years, respectively; p = 0.002) with similar diagnostic delay. EoE symptoms varied significantly between sexes, with food impaction predominating in males and dysphagia, heartburn, regurgitation and abdominal and epigastric pain in females. However, female sex contributed to higher symptom severity at diagnosis as measured with Dysphagia Symptom Score ( R 2 = 0.57; p = 0.013) and presented higher peak eosinophil count in esophageal biopsies ( p = 0.005). Males showed increased risk of stricturing or mixed phenotypes (adjusted OR 1.43, 95%CI:1.05–1.96; p = 0.024). No association was found between patients’ sex and first‐line treatment modality: proton pump inhibitors (PPI) were preferred over topical corticosteroids in patients with inflammatory phenotypes instead of stricturing or mixed phenotypes, and in patients who did not present food impaction. Both topical corticosteroids and dietary interventions were preferred over PPI in pediatric patients regardless of sex. Conclusions: Sex is associated with clinical and phenotypical presentation of EoE at diagnosis, with more fibrotic findings in males but higher symptom score in females.
- 8 November 2024
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (10) , 1388-1398
Open AccessSex‐related differences in the presentation, management and response to treatment of eosinophilic esophagitis: Cross sectional analysis of EoE CONNECT registry
Background: Eosinophilic esophagitis (EoE) predominantly affects males across all ages; however, little is known about sex differences for other aspects of EoE. Objective: To investigate associations between sex and clinical presentation, endoscopic features, treatment choice and response in EoE patients in real‐world practice. Methods: Cross‐sectional analysis of the multicenter EoE CONNECT registry. The independent contribution of patients' sex and other relevant variables were statistically assessed by multivariate models. Results: A total of 2976 patients (76% male) were evaluated. Males were diagnosed at a younger age compared to females (32.7 ± 14.8 vs. 34.8 ± 15.6 years, respectively; p = 0.002) with similar diagnostic delay. EoE symptoms varied significantly between sexes, with food impaction predominating in males and dysphagia, heartburn, regurgitation and abdominal and epigastric pain in females. However, female sex contributed to higher symptom severity at diagnosis as measured with Dysphagia Symptom Score ( R 2 = 0.57; p = 0.013) and presented higher peak eosinophil count in esophageal biopsies ( p = 0.005). Males showed increased risk of stricturing or mixed phenotypes (adjusted OR 1.43, 95%CI:1.05–1.96; p = 0.024). No association was found between patients’ sex and first‐line treatment modality: proton pump inhibitors (PPI) were preferred over topical corticosteroids in patients with inflammatory phenotypes instead of stricturing or mixed phenotypes, and in patients who did not present food impaction. Both topical corticosteroids and dietary interventions were preferred over PPI in pediatric patients regardless of sex. Conclusions: Sex is associated with clinical and phenotypical presentation of EoE at diagnosis, with more fibrotic findings in males but higher symptom score in females.
- Open Access
- 29 January 2024
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (5) , 585-595
Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real‐world efficacy from the EoE CONNECT registry
Background: Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have occurred due to their active ingredients, formulations and doses.Objective: To assess the effectiveness of topical corticosteroid therapy for EoE in real‐world practice.Methods: Cross‐sectional study analysis of the multicentre EoE CONNECT registry. Clinical remission was defined as a decrease of ≥50% in dysphagia symptom scores; histological remission was defined as a peak eosinophil count below 15 per high‐power field. The effectiveness in achieving clinico‐histological remission (CHR) was compared for the main tC formulations.Results: Overall, data on 1456 prescriptions of tC in monotherapy used in 866 individual patients were assessed. Of those, 904 prescriptions with data on formulation were employed for the induction of remission; 234 reduced a previously effective dose for maintenance. Fluticasone propionate formulations dominated the first‐line treatment, while budesonide was more common in later therapies. A swallowed nasal drop suspension was the most common formulation of fluticasone propionate. Doses ≥0.8 mg/day provided a 65% CHR rate and were superior to lower doses. Oral viscous solution prepared by a pharmacist was the most common prescription of budesonide; 4 mg/day provided no benefit over 2 mg/day (CHR rated being 72% and 80%, respectively). A multivariate analysis revealed budesonide orodispersible tablets as the most effective therapy (OR 18.9, p < 0.001); use of higher doses (OR 4.3, p = 0.03) and lower symptom scores (OR 0.9, p = 0.01) were also determinants of effectiveness.Conclusion: Reduced symptom severity, use of high doses, and use of budesonide orodispersible tablets particularly were all independent predictors of tC effectiveness.
- 29 January 2024
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (5) , 585-595
Open AccessSwallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real‐world efficacy from the EoE CONNECT registry
Background: Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have occurred due to their active ingredients, formulations and doses.Objective: To assess the effectiveness of topical corticosteroid therapy for EoE in real‐world practice.Methods: Cross‐sectional study analysis of the multicentre EoE CONNECT registry. Clinical remission was defined as a decrease of ≥50% in dysphagia symptom scores; histological remission was defined as a peak eosinophil count below 15 per high‐power field. The effectiveness in achieving clinico‐histological remission (CHR) was compared for the main tC formulations.Results: Overall, data on 1456 prescriptions of tC in monotherapy used in 866 individual patients were assessed. Of those, 904 prescriptions with data on formulation were employed for the induction of remission; 234 reduced a previously effective dose for maintenance. Fluticasone propionate formulations dominated the first‐line treatment, while budesonide was more common in later therapies. A swallowed nasal drop suspension was the most common formulation of fluticasone propionate. Doses ≥0.8 mg/day provided a 65% CHR rate and were superior to lower doses. Oral viscous solution prepared by a pharmacist was the most common prescription of budesonide; 4 mg/day provided no benefit over 2 mg/day (CHR rated being 72% and 80%, respectively). A multivariate analysis revealed budesonide orodispersible tablets as the most effective therapy (OR 18.9, p < 0.001); use of higher doses (OR 4.3, p = 0.03) and lower symptom scores (OR 0.9, p = 0.01) were also determinants of effectiveness.Conclusion: Reduced symptom severity, use of high doses, and use of budesonide orodispersible tablets particularly were all independent predictors of tC effectiveness.
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S360
Magnetic balloon technology for solving colon loops: first in human clinical trial
Aims A colonoscopy CE marked add-on device (Endorail by Endostart srl, Certaldo, Italy) was developed to straighten loops and facilitate colonoscope positioning and progression. The aim of the study is to evaluate the safety and efficacy of magnetic balloon technology in solving colon loops. Methods An open-label, not-controlled, prospective, single-center, interventional trial was conducted at Humanitas Research Hospital. Looping development and resolution was demonstrated by clinical judgement. Pain was recorded 30 minutes after the procedure using a visual analogue scale (VAS). A phone follow-up visit was scheduled after 7 days. Endorail is composed by a balloon catheter that can be inserted on demand in the 3,7 adult colonoscope tool channel, then filled with a syringe of ferromagnetic fluid and anchored with an external permanent magnet. Results Six caucasian patients (42-64 yrs, 4 males, BMI: 19,6-24,1) were enrolled between February 11, 2020 and March 11, 2020. In 5 patients, magnetic anchorage was achieved, balloon undocking did not occur during the straightening maneuvers and the loop was always solved. One patient, due to the use of a colonoscope channel has been excluded from the analysis. All 6 patients regularly completed the colonoscopy. No device deficiencies or malfunctions occurred. No patient experienced pain within 30 minutes after completing the procedure (VAS: 0). None of the 6 participant patients experienced adverse. Conclusions This first clinical study provided preliminary evidence that magnetic balloon technology is safe and effective in solving colon loops. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S360
Magnetic balloon technology for solving colon loops: first in human clinical trial
Aims A colonoscopy CE marked add-on device (Endorail by Endostart srl, Certaldo, Italy) was developed to straighten loops and facilitate colonoscope positioning and progression. The aim of the study is to evaluate the safety and efficacy of magnetic balloon technology in solving colon loops. Methods An open-label, not-controlled, prospective, single-center, interventional trial was conducted at Humanitas Research Hospital. Looping development and resolution was demonstrated by clinical judgement. Pain was recorded 30 minutes after the procedure using a visual analogue scale (VAS). A phone follow-up visit was scheduled after 7 days. Endorail is composed by a balloon catheter that can be inserted on demand in the 3,7 adult colonoscope tool channel, then filled with a syringe of ferromagnetic fluid and anchored with an external permanent magnet. Results Six caucasian patients (42-64 yrs, 4 males, BMI: 19,6-24,1) were enrolled between February 11, 2020 and March 11, 2020. In 5 patients, magnetic anchorage was achieved, balloon undocking did not occur during the straightening maneuvers and the loop was always solved. One patient, due to the use of a colonoscope channel has been excluded from the analysis. All 6 patients regularly completed the colonoscopy. No device deficiencies or malfunctions occurred. No patient experienced pain within 30 minutes after completing the procedure (VAS: 0). None of the 6 participant patients experienced adverse. Conclusions This first clinical study provided preliminary evidence that magnetic balloon technology is safe and effective in solving colon loops. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 16 May 2022
- Published by Wiley in United European Gastroenterology Journal
- Vol. 10 (5) , 507-517
Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry
Background: Poor adherence to clinical practice guidelines for eosinophilic esophagitis (EoE) has been described and the diagnostic delay of the disease continues to be unacceptable in many settings.Objective: To analyze the impact of improved knowledge provided by the successive international clinical practice guidelines on reducing diagnostic delay and improving the diagnostic process for European patients with EoE.Methods: Cross‐sectional analysis of the EoE CONNECT registry based on clinical practice. Time periods defined by the publication dates of four major sets of guidelines over 10 years were considered. Patients were grouped per time period according to date of symptom onset.Results: Data from 1,132 patients was analyzed and median (IQR) diagnostic delay in the whole series was 2.1 (0.7‐6.2) years. This gradually decreased over time with subsequent release of new guidelines (p < 0.001), from 12.7 years up to 2007 to 0.7 years after 2017. The proportion of patients with stricturing of mixed phenotypes at the point of EoE diagnosis also decreased over time (41.3% vs. 16%; p < 0.001), as did EREFS scores. The fibrotic sub‐score decreased from a median (IQR) of 2 (1‐2) to 0 (0‐1) when patients whose symptoms started up to 2007 and after 2017 were compared (p < 0.001). In parallel, symptoms measured with the Dysphagia Symptoms Score reduced significantly when patients with symptoms starting before 2007 and after 2012 were compared. A reduction in the number of endoscopies patients underwent before the one that achieved an EoE diagnosis, and the use of allergy testing as part of the diagnostic workout of EoE, also reduced significantly over time (p = 0.010 and p < 0.001, respectively).Conclusion: The diagnostic work‐up of EoE patients improved substantially over time at the European sites contributing to EoE CONNECT, with a dramatic reduction in diagnostic delay.
- 16 May 2022
- Published by Wiley in United European Gastroenterology Journal
- Vol. 10 (5) , 507-517
Open AccessAccurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry
Background: Poor adherence to clinical practice guidelines for eosinophilic esophagitis (EoE) has been described and the diagnostic delay of the disease continues to be unacceptable in many settings.Objective: To analyze the impact of improved knowledge provided by the successive international clinical practice guidelines on reducing diagnostic delay and improving the diagnostic process for European patients with EoE.Methods: Cross‐sectional analysis of the EoE CONNECT registry based on clinical practice. Time periods defined by the publication dates of four major sets of guidelines over 10 years were considered. Patients were grouped per time period according to date of symptom onset.Results: Data from 1,132 patients was analyzed and median (IQR) diagnostic delay in the whole series was 2.1 (0.7‐6.2) years. This gradually decreased over time with subsequent release of new guidelines (p < 0.001), from 12.7 years up to 2007 to 0.7 years after 2017. The proportion of patients with stricturing of mixed phenotypes at the point of EoE diagnosis also decreased over time (41.3% vs. 16%; p < 0.001), as did EREFS scores. The fibrotic sub‐score decreased from a median (IQR) of 2 (1‐2) to 0 (0‐1) when patients whose symptoms started up to 2007 and after 2017 were compared (p < 0.001). In parallel, symptoms measured with the Dysphagia Symptoms Score reduced significantly when patients with symptoms starting before 2007 and after 2012 were compared. A reduction in the number of endoscopies patients underwent before the one that achieved an EoE diagnosis, and the use of allergy testing as part of the diagnostic workout of EoE, also reduced significantly over time (p = 0.010 and p < 0.001, respectively).Conclusion: The diagnostic work‐up of EoE patients improved substantially over time at the European sites contributing to EoE CONNECT, with a dramatic reduction in diagnostic delay.
- 1 September 2021
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53, S191
AF.116 SUBMUCOSAL TUNNELLING TECHNIQUES FOR ZENKER’S DIVERTICULUM: A SYSTEMATIC REVIEW OF EARLY OUTCOMES WITH POOLED ANALYSIS
- 1 September 2021
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53, S191
AF.116 SUBMUCOSAL TUNNELLING TECHNIQUES FOR ZENKER’S DIVERTICULUM: A SYSTEMATIC REVIEW OF EARLY OUTCOMES WITH POOLED ANALYSIS
- Open Access
- 20 July 2020
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Medicine
- Vol. 41 (4) , 250-255
Usefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care
Gastroesophageal reflux disease is a digestive disorder characterized by nausea, regurgitation, and heartburn. Gastroesophageal reflux is the primary cause of laryngeal symptoms, especially chronic posterior laryngitis. The best diagnostic test for this disease is esophageal impedance-pH monitoring; however, it is poorly employed owing to its high cost and invasiveness. Salivary pepsin measured using a lateral flow device (Pep-test) has been suggested as an indirect marker of laryngopharyngeal reflux (LPR). The present study tested the reliability of Pep-test in diagnosing LPR in uninvestigated primary care attenders presenting with chronic laryngeal symptoms, and evaluated the raw pepsin concentration in patients with LPR. A multicenter, non-interventional pilot study was conducted on 86 suspected patients with LPR and 59 asymptomatic subjects as controls in three Italian primary care settings. A reflux symptom index questionnaire was used to differentiate patients with LPR (score >13) from controls (score <5). Two saliva samples were collected, and comparisons between the groups were performed using two-sided statistical tests, according to variable distributions. There was no statistical difference in the salivary pepsin positivity between LPR patients and controls, whereas the pepsin intensity value was higher in controls than in LPR patients. A high prevalence of pepsin positivity was observed in asymptomatic controls. Pepsin measurement should not be considered as a diagnostic test for LPR in primary care patients.
- 20 July 2020
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Medicine
- Vol. 41 (4) , 250-255
Open AccessUsefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care
Gastroesophageal reflux disease is a digestive disorder characterized by nausea, regurgitation, and heartburn. Gastroesophageal reflux is the primary cause of laryngeal symptoms, especially chronic posterior laryngitis. The best diagnostic test for this disease is esophageal impedance-pH monitoring; however, it is poorly employed owing to its high cost and invasiveness. Salivary pepsin measured using a lateral flow device (Pep-test) has been suggested as an indirect marker of laryngopharyngeal reflux (LPR). The present study tested the reliability of Pep-test in diagnosing LPR in uninvestigated primary care attenders presenting with chronic laryngeal symptoms, and evaluated the raw pepsin concentration in patients with LPR. A multicenter, non-interventional pilot study was conducted on 86 suspected patients with LPR and 59 asymptomatic subjects as controls in three Italian primary care settings. A reflux symptom index questionnaire was used to differentiate patients with LPR (score >13) from controls (score <5). Two saliva samples were collected, and comparisons between the groups were performed using two-sided statistical tests, according to variable distributions. There was no statistical difference in the salivary pepsin positivity between LPR patients and controls, whereas the pepsin intensity value was higher in controls than in LPR patients. A high prevalence of pepsin positivity was observed in asymptomatic controls. Pepsin measurement should not be considered as a diagnostic test for LPR in primary care patients.
- 23 April 2020
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 52 (S 01) , ePP45V
DILUMEN ENDOSCOPICSUBMUCOSAL DISSECTION OF THE ASCENDING COLON IN A RECCURRENT COLONIC LESION
The treatment of colonic recurrent lesions could be challanging especially for complex polyps. DiLumen Endolumenal Interventional Platform (EIP) improves endoscopic stability and visualization and it allows an effective tissue traction. A 59-year-old woman was referred to our center for a recurrent lesion. Colonoscopy documented a 20 millimeters sessile polyp involving a fold in the ascending colon. DiLumen was placed allowing a complete visualization of the lesion and the submucosal dissection was performed with a traction-assisted technique. The total procedural time was 33 minutes. This device can be a valuable tool in the armamentarium for the management of complex colonic lesions.
- 23 April 2020
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 52 (S 01) , ePP45V
DILUMEN ENDOSCOPICSUBMUCOSAL DISSECTION OF THE ASCENDING COLON IN A RECCURRENT COLONIC LESION
The treatment of colonic recurrent lesions could be challanging especially for complex polyps. DiLumen Endolumenal Interventional Platform (EIP) improves endoscopic stability and visualization and it allows an effective tissue traction. A 59-year-old woman was referred to our center for a recurrent lesion. Colonoscopy documented a 20 millimeters sessile polyp involving a fold in the ascending colon. DiLumen was placed allowing a complete visualization of the lesion and the submucosal dissection was performed with a traction-assisted technique. The total procedural time was 33 minutes. This device can be a valuable tool in the armamentarium for the management of complex colonic lesions.
- 23 April 2020
- Published by Georg Thieme Verlag KG
- Vol. 52 (S 01) , ePP332
ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR GASTRIC LESIONS: A SINGLE ITALIAN CENTER EXPERIENCE
Aims The aim of this study is to report the short- and long-term outcomes of a cohort of patients from a single Italian center who underwent gastric ESD. Methods A retrospective analysis of a prospectively mantained registry of all gastric ESDs performed at Humanitas Research Hospital during a 10-year period (January 2010 – January 2019) was performed. Expanded indication criteria for gastric ESD were used. Results During the study period, 158 consecutive gastric lesions were treated by ESD. On final pathology, 91 lesions were adenocarcinoma (57.4%) with a subclassification of pT1a: 56 (61.5%), pT1b: 31 (34.%) and pT2: 4 (4.4%). Thirty-eight lesions were diagnosed as high grade dysplasia (24.%), 23 were low grade dysplasia only (14.5.%) and 6 were non-adenomatous (3.8%). An en-bloc resection was achieved in 136 patients (86%). R0 resection was reported in 116 patients (73,4%), while 30 yielded a R1 resection (19%) and the remaining 12 procedures (7.6%) were classified as Rx. Twenty-two patients (14%) experienced a complication (11 early, 10 delayed, 1 both early and delayed). The most common complication was bleeding (17 patients, 10.7%) while 5 perforations (3%) were reported. All these complications were successfully treated endoscopically except 3 patients who required surgery. No deaths occurred related to the ESD procedure. Overall, 23 patients (14.5%) underwent surgery because of non-curative resections. Thirteen patients (8.2) were lost at follow-up. Mean follow-up was 37.2 months (range 122–3). During follow-up, 6 local recurrences of adenoma with LGD at the previous ESD site were diagnosed while 2 patients developed a cancer in a site different from ESD and were referred to surgery. Conclusions In a large western series of ESD for early gastric neoplasia ESD was associated with a significant proportion of curative resection and quite low rate of complications as well as disease recurrence.
- 23 April 2020
- Published by Georg Thieme Verlag KG
- Vol. 52 (S 01) , ePP332
ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR GASTRIC LESIONS: A SINGLE ITALIAN CENTER EXPERIENCE
Aims The aim of this study is to report the short- and long-term outcomes of a cohort of patients from a single Italian center who underwent gastric ESD. Methods A retrospective analysis of a prospectively mantained registry of all gastric ESDs performed at Humanitas Research Hospital during a 10-year period (January 2010 – January 2019) was performed. Expanded indication criteria for gastric ESD were used. Results During the study period, 158 consecutive gastric lesions were treated by ESD. On final pathology, 91 lesions were adenocarcinoma (57.4%) with a subclassification of pT1a: 56 (61.5%), pT1b: 31 (34.%) and pT2: 4 (4.4%). Thirty-eight lesions were diagnosed as high grade dysplasia (24.%), 23 were low grade dysplasia only (14.5.%) and 6 were non-adenomatous (3.8%). An en-bloc resection was achieved in 136 patients (86%). R0 resection was reported in 116 patients (73,4%), while 30 yielded a R1 resection (19%) and the remaining 12 procedures (7.6%) were classified as Rx. Twenty-two patients (14%) experienced a complication (11 early, 10 delayed, 1 both early and delayed). The most common complication was bleeding (17 patients, 10.7%) while 5 perforations (3%) were reported. All these complications were successfully treated endoscopically except 3 patients who required surgery. No deaths occurred related to the ESD procedure. Overall, 23 patients (14.5%) underwent surgery because of non-curative resections. Thirteen patients (8.2) were lost at follow-up. Mean follow-up was 37.2 months (range 122–3). During follow-up, 6 local recurrences of adenoma with LGD at the previous ESD site were diagnosed while 2 patients developed a cancer in a site different from ESD and were referred to surgery. Conclusions In a large western series of ESD for early gastric neoplasia ESD was associated with a significant proportion of curative resection and quite low rate of complications as well as disease recurrence.